Why the study?
Does a sirolimus-eluting stent reduce restenosis and associated clinical events compared to standard stents in patients with stenosis in a native coronary artery?
Does a sirolimus-eluting stent reduce restenosis and associated clinical events compared to standard stents in patients with stenosis in a native coronary artery?
Sirolimus-eluting stents are effective at reducing restenosis and associated clinical events in patients with complex coronary lesions.
No takes yet. Share an insight, caveat, or question.
Supports first-line sirolimus-eluting stent use in native coronary stenosis; confirms consistent benefit across all subgroups.
Moses et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: